Sign in to view content

APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD

Michael N. Cohen, MD

Video
Published 2020

Related

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results
Pravin U. Dugel, MD
Updates from the Field
2018
Retinal Physician Practice Patterns in the Setting of Anticoagulation
Allen Chiang, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated With Vitreoretinal Surgery
Daniel F. Kiernan, MD, FACS
Annual Meeting Talks
2020

Category: Age-Related Macular Degeneration

See more